Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.710
+0.020 (1.18%)
Jul 20, 2026, 3:37 PM EST
Cardiol Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
194.81M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 78.76K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cresco Labs | 895.33M |
| Ascend Wellness Holdings | 683.30M |
| TerrAscend | 365.43M |
| Aurora Cannabis | 320.59M |
| Organigram Global | 274.19M |
| Auxly Cannabis Group | 158.57M |
| Medexus Pharmaceuticals | 138.65M |
| Cannara Biotech | 117.40M |
Cardiol Therapeutics News
- 6 days ago - Cardiol Therapeutics (CRDL) Publishes Phase II Study Findings in JAHA - GuruFocus
- 6 days ago - Cardiol Therapeutics’ CardiolRx featured in Phase 2 pericarditis published trial - TheFly
- 6 days ago - Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association - PRNewsWire
- 11 days ago - Cardiol Therapeutics (CRDL) to Attend B. Riley Securities Summit in Boston - GuruFocus
- 11 days ago - Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit - PRNewsWire
- 25 days ago - Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders - PRNewsWire
- 27 days ago - Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT - PRNewsWire
- 2 months ago - Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ - PRNewsWire